In the TME, TAM survival depends on the colony-stimulating factor (CSF)-1/CSF1R pathway; blocking CSF1/CSF1R has been proven to significantly reduce macrophage recruitment and M2 polarization and induce activation of CD8+ T-cells, thereby sensitizing tumor to ICI and prolonged survival in several other cancer types (176). This evidence concerns the gene CSF2 and neoplasm.